Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 159 entries
Sorted by: Best Match Show Resources per page
The relationship of gender, experiential, and psychological factors to achievement in computer science

Broadening Participation in Computing AND Program Evaluation

Boyer KE, Hinckle M, Mott B, Rachmatullah A.
GSID: 49Rpwj_9rfwJ
M Hinckle, A Rachmatullah, B Mott, KE Boyer… - … technology in computer …, 2020 - dl.acm.org

Computer science (CS) is widely recognized as a field with a significant gender gap despite the growing prevalence of computing. Several factors including CS attitudes, exposure to CS, experience with computer programming, and confidence in using computers are understood...

Cite
Hinckle, M., Rachmatullah, A., Mott, B., Boyer, K. E., Lester, J., & Wiebe, E. (2020, June). The relationship of gender, experiential, and psychological factors to achievement in computer science. In Proceedings of the 2020 ACM conference on innovation and technology in computer science education (pp. 225-231).
Hinckle, Madeline, et al. "The relationship of gender, experiential, and psychological factors to achievement in computer science." Proceedings of the 2020 ACM conference on innovation and technology in computer science education. 2020.
Copy Download .nbib Format: MLA
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.

JMIR mHealth and uHealth

Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J, Hanina A.
PMID: 28223265
JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e18. doi: 10.2196/mhealth.7030.

BACKGROUND: Accurately monitoring and collecting drug adherence data can allow for better understanding and interpretation of the outcomes of clinical trials. Most clinical trials use a combination of pill counts and self-reported data to measure drug adherence, despite the...

Cite
Bain EE, Shafner L, Walling DP, et al. Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia. JMIR Mhealth Uhealth. 2017;5(2):e18doi: 10.2196/mhealth.7030.
Bain, E. E., Shafner, L., Walling, D. P., Othman, A. A., Chuang-Stein, C., Hinkle, J., & Hanina, A. (2017). Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia. JMIR mHealth and uHealth, 5(2), e18. https://doi.org/10.2196/mhealth.7030
Bain, Earle E, et al. "Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia." JMIR mHealth and uHealth vol. 5,2 (2017): e18. doi: https://doi.org/10.2196/mhealth.7030
Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J, Hanina A. Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia. JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e18. doi: 10.2196/mhealth.7030. PMID: 28223265; PMCID: PMC5340925.
Copy Download .nbib Format: NLM
Complete Genome Sequence of .

Genome announcements

Galac MR, Stam J, Maybank R, Hinkle M, Mack D, Rohde H, Roth AL, Fey PD.
PMID: 28572323
Genome Announc. 2017 Jun 01;5(22). doi: 10.1128/genomeA.00450-17.

No abstract available.

Cite
Galac MR, Stam J, Maybank R, et al. Complete Genome Sequence of . Genome Announc. 2017;5(22)doi: 10.1128/genomeA.00450-17.
Galac, M. R., Stam, J., Maybank, R., Hinkle, M., Mack, D., Rohde, H., Roth, A. L., & Fey, P. D. (2017). Complete Genome Sequence of . Genome announcements, 5(22), . https://doi.org/10.1128/genomeA.00450-17
Galac, Madeline R, et al. "Complete Genome Sequence of ." Genome announcements vol. 5,22 (2017). doi: https://doi.org/10.1128/genomeA.00450-17
Galac MR, Stam J, Maybank R, Hinkle M, Mack D, Rohde H, Roth AL, Fey PD. Complete Genome Sequence of . Genome Announc. 2017 Jun 01;5(22). doi: 10.1128/genomeA.00450-17. PMID: 28572323; PMCID: PMC5454206.
Copy Download .nbib Format: NLM
Elementspezifische Analyse einer Hyperpigmentierung infolge Levofloxacin-Therapie.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Dinkel G, Kofler L, Sönnichsen K, Fehrenbacher B, Metzler G, Schaller M.
PMID: 28872227
J Dtsch Dermatol Ges. 2017 Sep;15(9):948-950. doi: 10.1111/ddg.13314_g.

No abstract available.

Cite
Dinkel G, Kofler L, Sönnichsen K, et al. Elementspezifische Analyse einer Hyperpigmentierung infolge Levofloxacin-Therapie. J Dtsch Dermatol Ges. 2017;15(9):948-950doi: 10.1111/ddg.13314_g.
Dinkel, G., Kofler, L., Sönnichsen, K., Fehrenbacher, B., Metzler, G., & Schaller, M. (2017). Elementspezifische Analyse einer Hyperpigmentierung infolge Levofloxacin-Therapie. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 15(9), 948-950. https://doi.org/10.1111/ddg.13314_g
Dinkel, Gwendolyn, et al. "Elementspezifische Analyse einer Hyperpigmentierung infolge Levofloxacin-Therapie." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 15,9 (2017): 948-950. doi: https://doi.org/10.1111/ddg.13314_g
Dinkel G, Kofler L, Sönnichsen K, Fehrenbacher B, Metzler G, Schaller M. Elementspezifische Analyse einer Hyperpigmentierung infolge Levofloxacin-Therapie. J Dtsch Dermatol Ges. 2017 Sep;15(9):948-950. doi: 10.1111/ddg.13314_g. PMID: 28872227.
Copy Download .nbib Format: NLM
The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.

Current pulmonology reports

Novosad S, Henkle E, Winthrop KL.
PMID: 26877911
Curr Pulmonol Rep. 2015 Sep 01;4(3):152-161. doi: 10.1007/s13665-015-0119-3. Epub 2015 Jul 12.

The incidence of nontuberculous mycobacterial (NTM) lung disease is increasing. Current treatment strategies are largely based on expert opinion. The lack of randomized clinical trials to inform treatment leave clinicians with many questions regarding the most effective and safe...

Cite
Novosad S, Henkle E, Winthrop KL. The Challenge of Pulmonary Nontuberculous Mycobacterial Infection. Curr Pulmonol Rep. 2015;4(3):152-161doi: 10.1007/s13665-015-0119-3.
Novosad, S., Henkle, E., & Winthrop, K. L. (2015). The Challenge of Pulmonary Nontuberculous Mycobacterial Infection. Current pulmonology reports, 4(3), 152-161. https://doi.org/10.1007/s13665-015-0119-3
Novosad, Shannon, et al. "The Challenge of Pulmonary Nontuberculous Mycobacterial Infection." Current pulmonology reports vol. 4,3 (2015): 152-161. doi: https://doi.org/10.1007/s13665-015-0119-3
Novosad S, Henkle E, Winthrop KL. The Challenge of Pulmonary Nontuberculous Mycobacterial Infection. Curr Pulmonol Rep. 2015 Sep 01;4(3):152-161. doi: 10.1007/s13665-015-0119-3. Epub 2015 Jul 12. PMID: 26877911; PMCID: PMC4749270.
Copy Download .nbib Format: NLM
Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T

Desai DC, Arnold M, Saha S, Hinkle G, Soble D, Fry J, DePalatis LR, Mantil J, Satter M, Martin EW.
PMID: 11348847
Clin Positron Imaging. 2000 Sep;3(5):189-196. doi: 10.1016/s1095-0397(00)00052-2.

Purpose: 18F-Fluorodeoxyglucose-positron emission tomography (FDG-PET) is the superior imaging modality for detection of primary and recurrent colorectal cancer compared to magnetic resonance imaging (MRI) or computerized tomography (CT). We investigated the feasibility of developing intraoperative procedures for detection of...

Cite
Desai DC, Arnold M, Saha S, et al. Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. Clin Positron Imaging. 2000;3(5):189-196doi: 10.1016/s1095-0397(00)00052-2.
Desai, D. C., Arnold, M., Saha, S., Hinkle, G., Soble, D., Fry, J., DePalatis, L. R., Mantil, J., Satter, M., & Martin, E. W. (2000). Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. Clinical positron imaging : official journal of the Institute for Clinical P.E.T, 3(5), 189-196. https://doi.org/10.1016/s1095-0397(00)00052-2
Desai, D C., et al. "Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer." Clinical positron imaging : official journal of the Institute for Clinical P.E.T vol. 3,5 (2000): 189-196. doi: https://doi.org/10.1016/s1095-0397(00)00052-2
Desai DC, Arnold M, Saha S, Hinkle G, Soble D, Fry J, DePalatis LR, Mantil J, Satter M, Martin EW. Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. Clin Positron Imaging. 2000 Sep;3(5):189-196. doi: 10.1016/s1095-0397(00)00052-2. PMID: 11348847.
Copy Download .nbib Format: NLM
Localization of Neuroendocrine Tumors Using Somatostatin Receptor Imaging With Indium-111-Pentetreotide (OctreoScan).

Cancer control : journal of the Moffitt Cancer Center

Ellison EC, Schirmer WJ, Olsen JO, Pozderac RV, Hinkle G, Hill T, O'Dorisio TM, O'Dorisio MS.
PMID: 10763002
Cancer Control. 1997 Jan;4(1):35-39.

BACKGROUND: Many imaging methods have been used to detect neuroendocrine tumors of the gastrointestinal system. There is no gold standard for identifying the location of primary tumors and their potential metastases, and most conventional imaging techniques cannot detect tumors...

Cite
Ellison EC, Schirmer WJ, Olsen JO, et al. Localization of Neuroendocrine Tumors Using Somatostatin Receptor Imaging With Indium-111-Pentetreotide (OctreoScan). Cancer Control. 1997;4(1):35-39
Ellison, E. C., Schirmer, W. J., Olsen, J. O., Pozderac, R. V., Hinkle, G., Hill, T., O'Dorisio, T. M., & O'Dorisio, M. S. (1997). Localization of Neuroendocrine Tumors Using Somatostatin Receptor Imaging With Indium-111-Pentetreotide (OctreoScan). Cancer control : journal of the Moffitt Cancer Center, 4(1), 35-39.
Ellison, et al. "Localization of Neuroendocrine Tumors Using Somatostatin Receptor Imaging With Indium-111-Pentetreotide (OctreoScan)." Cancer control : journal of the Moffitt Cancer Center vol. 4,1 (1997): 35-39.
Ellison EC, Schirmer WJ, Olsen JO, Pozderac RV, Hinkle G, Hill T, O'Dorisio TM, O'Dorisio MS. Localization of Neuroendocrine Tumors Using Somatostatin Receptor Imaging With Indium-111-Pentetreotide (OctreoScan). Cancer Control. 1997 Jan;4(1):35-39. PMID: 10763002.
Copy Download .nbib Format: NLM
VITAMIN C SATURATION LEVELS IN THE BODY IN NORMAL SUBJECTS AND IN VARIOUS PATHOLOGICAL CONDITIONS.

The Journal of clinical investigation

Finkle P.
PMID: 16694506
J Clin Invest. 1937 Jul;16(4):587-93. doi: 10.1172/JCI100885.

No abstract available.

Cite
Finkle P. VITAMIN C SATURATION LEVELS IN THE BODY IN NORMAL SUBJECTS AND IN VARIOUS PATHOLOGICAL CONDITIONS. J Clin Invest. 1937;16(4):587-93doi: 10.1172/JCI100885.
Finkle, P. (1937). VITAMIN C SATURATION LEVELS IN THE BODY IN NORMAL SUBJECTS AND IN VARIOUS PATHOLOGICAL CONDITIONS. The Journal of clinical investigation, 16(4), 587-93. https://doi.org/10.1172/JCI100885
Finkle, P. "VITAMIN C SATURATION LEVELS IN THE BODY IN NORMAL SUBJECTS AND IN VARIOUS PATHOLOGICAL CONDITIONS." The Journal of clinical investigation vol. 16,4 (1937): 587-93. doi: https://doi.org/10.1172/JCI100885
Finkle P. VITAMIN C SATURATION LEVELS IN THE BODY IN NORMAL SUBJECTS AND IN VARIOUS PATHOLOGICAL CONDITIONS. J Clin Invest. 1937 Jul;16(4):587-93. doi: 10.1172/JCI100885. PMID: 16694506; PMCID: PMC424898.
Copy Download .nbib Format: NLM
Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T

Desai D, Arnold M, Saha S, Hinkle G, Soble D, Frye J, DePalatis L, Mantil J, Satter M, Martin E.
PMID: 14516622
Clin Positron Imaging. 1999 Nov;2(6):325. doi: 10.1016/s1095-0397(99)00085-0.

No abstract available.

Cite
Desai D, Arnold M, Saha S, et al. Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. Clin Positron Imaging. 1999;2(6):325doi: 10.1016/s1095-0397(99)00085-0.
Desai, D., Arnold, M., Saha, S., Hinkle, G., Soble, D., Frye, J., DePalatis, L., Mantil, J., Satter, M., & Martin, E. (1999). Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. Clinical positron imaging : official journal of the Institute for Clinical P.E.T, 2(6), 325. https://doi.org/10.1016/s1095-0397(99)00085-0
Desai, D, et al. "Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer." Clinical positron imaging : official journal of the Institute for Clinical P.E.T vol. 2,6 (1999): 325. doi: https://doi.org/10.1016/s1095-0397(99)00085-0
Desai D, Arnold M, Saha S, Hinkle G, Soble D, Frye J, DePalatis L, Mantil J, Satter M, Martin E. Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. Clin Positron Imaging. 1999 Nov;2(6):325. doi: 10.1016/s1095-0397(99)00085-0. PMID: 14516622.
Copy Download .nbib Format: NLM
N-[Bis(dimethyl-amino)-methyl-idene]-2-[(triphenyl-meth-yl)sulfan-yl]ethanaminium hexa-fluoro-phosphate.

Acta crystallographica. Section E, Structure reports online

Neuba A, Flörke U, Henkel G.
PMID: 21754533
Acta Crystallogr Sect E Struct Rep Online. 2011 May 01;67:o1238-9. doi: 10.1107/S1600536811014929. Epub 2011 Apr 29.

The mol-ecular structure of the title compound, C(26)H(32)N(3)S(+)·PF(6) (-), shows a protonated guanidyl group bridged by an ethyl-ene linker with a tritylsulfanyl unit. The guanidinium (gua) unit displays charge delocalization over the three N-C(gua) bonds. The N-C-C-S group shows...

Cite
Neuba A, Flörke U, Henkel G. N-[Bis(dimethyl-amino)-methyl-idene]-2-[(triphenyl-meth-yl)sulfan-yl]ethanaminium hexa-fluoro-phosphate. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o1238-9doi: 10.1107/S1600536811014929.
Neuba, A., Flörke, U., & Henkel, G. (2011). N-[Bis(dimethyl-amino)-methyl-idene]-2-[(triphenyl-meth-yl)sulfan-yl]ethanaminium hexa-fluoro-phosphate. Acta crystallographica. Section E, Structure reports online, 67o1238-9. https://doi.org/10.1107/S1600536811014929
Neuba, Adam, et al. "N-[Bis(dimethyl-amino)-methyl-idene]-2-[(triphenyl-meth-yl)sulfan-yl]ethanaminium hexa-fluoro-phosphate." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o1238-9. doi: https://doi.org/10.1107/S1600536811014929
Neuba A, Flörke U, Henkel G. N-[Bis(dimethyl-amino)-methyl-idene]-2-[(triphenyl-meth-yl)sulfan-yl]ethanaminium hexa-fluoro-phosphate. Acta Crystallogr Sect E Struct Rep Online. 2011 May 01;67:o1238-9. doi: 10.1107/S1600536811014929. Epub 2011 Apr 29. PMID: 21754533; PMCID: PMC3089070.
Copy Download .nbib Format: NLM
Bis{1-[2-(diphenyl-phosphino)-ethyl]-3-ethylimidazol-2-yl-idene}palladium(II) bis-(hexa-fluoridophosphate) acetonitrile 2.85-solvate.

Acta crystallographica. Section E, Structure reports online

Aziza AA, Flörke U, Egold H, Henkel G.
PMID: 21579017
Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 14;66:m522. doi: 10.1107/S160053681001319X.

In the structure of the title compound, [Pd(C(19)H(21)N(2)P)(2)](PF(6))(2)·2.85CH(3)CN, the two six-membered NHC-phosphane chelate rings form a distorted square-planar coordination geometry around the Pd(II) atom, which lies 0.212 (1) Å above the coordination plane. The sum of the bond angles...

Cite
Aziza AA, Flörke U, Egold H, et al. Bis{1-[2-(diphenyl-phosphino)-ethyl]-3-ethylimidazol-2-yl-idene}palladium(II) bis-(hexa-fluoridophosphate) acetonitrile 2.85-solvate. Acta Crystallogr Sect E Struct Rep Online. 2010;66:m522doi: 10.1107/S160053681001319X.
Aziza, A. A., Flörke, U., Egold, H., & Henkel, G. (2010). Bis{1-[2-(diphenyl-phosphino)-ethyl]-3-ethylimidazol-2-yl-idene}palladium(II) bis-(hexa-fluoridophosphate) acetonitrile 2.85-solvate. Acta crystallographica. Section E, Structure reports online, 66m522. https://doi.org/10.1107/S160053681001319X
Aziza, A Ahmida, et al. "Bis{1-[2-(diphenyl-phosphino)-ethyl]-3-ethylimidazol-2-yl-idene}palladium(II) bis-(hexa-fluoridophosphate) acetonitrile 2.85-solvate." Acta crystallographica. Section E, Structure reports online vol. 66 (2010): m522. doi: https://doi.org/10.1107/S160053681001319X
Aziza AA, Flörke U, Egold H, Henkel G. Bis{1-[2-(diphenyl-phosphino)-ethyl]-3-ethylimidazol-2-yl-idene}palladium(II) bis-(hexa-fluoridophosphate) acetonitrile 2.85-solvate. Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 14;66:m522. doi: 10.1107/S160053681001319X. PMID: 21579017; PMCID: PMC2979058.
Copy Download .nbib Format: NLM
PAZ6 cells constitute a representative model for human brown pre-adipocytes.

Frontiers in endocrinology

Kazantzis M, Takahashi V, Hinkle J, Kota S, Zilberfarb V, Issad T, Abdelkarim M, Chouchane L, Strosberg AD.
PMID: 22649407
Front Endocrinol (Lausanne). 2012 Feb 02;3:13. doi: 10.3389/fendo.2012.00013. eCollection 2012.

The role of brown adipose tissue (BAT) in human metabolism and its potential as an anti-obesity target organ have recently received much renewed attention. Following radiological detection of substantial amounts of BAT in adults by several independent research groups,...

Cite
Kazantzis M, Takahashi V, Hinkle J, et al. PAZ6 cells constitute a representative model for human brown pre-adipocytes. Front Endocrinol (Lausanne). 2012;3:13doi: 10.3389/fendo.2012.00013.
Kazantzis, M., Takahashi, V., Hinkle, J., Kota, S., Zilberfarb, V., Issad, T., Abdelkarim, M., Chouchane, L., & Strosberg, A. D. (2012). PAZ6 cells constitute a representative model for human brown pre-adipocytes. Frontiers in endocrinology, 313. https://doi.org/10.3389/fendo.2012.00013
Kazantzis, Melissa, et al. "PAZ6 cells constitute a representative model for human brown pre-adipocytes." Frontiers in endocrinology vol. 3 (2012): 13. doi: https://doi.org/10.3389/fendo.2012.00013
Kazantzis M, Takahashi V, Hinkle J, Kota S, Zilberfarb V, Issad T, Abdelkarim M, Chouchane L, Strosberg AD. PAZ6 cells constitute a representative model for human brown pre-adipocytes. Front Endocrinol (Lausanne). 2012 Feb 02;3:13. doi: 10.3389/fendo.2012.00013. eCollection 2012. PMID: 22649407; PMCID: PMC3355992.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 159 entries